Strata Skin Sciences (NASDAQ:SSKN – Get Free Report)‘s stock had its “sell (e+)” rating reaffirmed by stock analysts at Weiss Ratings in a research report issued on Saturday,Weiss Ratings reports.
Separately, Wall Street Zen upgraded Strata Skin Sciences to a “sell” rating in a research note on Saturday, October 18th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Strata Skin Sciences presently has a consensus rating of “Hold” and a consensus price target of $6.00.
View Our Latest Stock Analysis on SSKN
Strata Skin Sciences Price Performance
Strata Skin Sciences (NASDAQ:SSKN – Get Free Report) last announced its quarterly earnings results on Wednesday, August 13th. The medical device company reported ($0.60) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.33). The business had revenue of $7.70 million for the quarter, compared to analysts’ expectations of $8.56 million. Strata Skin Sciences had a negative return on equity of 266.94% and a negative net margin of 35.13%. Equities analysts expect that Strata Skin Sciences will post -1.05 EPS for the current fiscal year.
Strata Skin Sciences Company Profile
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Featured Stories
- Five stocks we like better than Strata Skin Sciences
- Top Biotech Stocks: Exploring Innovation Opportunities
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- Using the MarketBeat Dividend Tax Calculator
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Is Landstar the Next Big Winner in Transportation Stocks?
Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
